Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours Β· Estimated delivery Oct 11 - Oct 16
751 participants across 32 sites in the United States and Puerto Rico 72-week treatment duration 1:1 randomization to Tirzepatide or Semaglutide Maximum tolerated dose used for both medications Primary endpoint: percent change in body weight at week 72 Participants received either the maximum tolerated dose of Tirzepatide (10mg or 15mg) or the maximum tolerated dose of Semaglutide (1.7mg or 2.4mg)
Protective Effects : Enhances blood circulation, promotes tissue repair, and improves gut health
L., Sly, W
Follow your compounded label and prescriber
Tissue-related and regenerative research models , where structural integrity, matrix remodeling, or barrier function are endpoints
US$ 20.68
US$ 24.37
US$ 24.16
US$ 23.78
US$ 26.57
US$ 29.91
